QA: Intelgenx Technologies Corp in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001098880_2024_Intelgenx_Technologies_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001098880, Intelgenx Technologies Corp

  xvar xval
0 AssetsCurrent 3,441,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,958,000
3 remainder_Assets 883,000
4 LiabilitiesCurrent 8,423,000
5 LiabilitiesNoncurrent 230,000
6 remainder_Liabilities 11,876,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,764,673
9 ResearchAndDevelopmentExpense 3,278,060
10 remainder_Expenses 2,515,569
11 remainder_Revenues 1,062,787
12 remainder_NetIncome -597,227
13 remainder_ComprehensiveNetIncome -444,817
  yvar yval
0 Assets 8,282,000
1 Liabilities 20,529,000
2 Expenses 10,558,302
3 Revenues 1,062,787
4 StockholdersEquity -12,247,000
5 NetIncome -10,092,742
6 ComprehensiveNetIncome -10,315,150
7 BaseVar 20,737,066
8 EconomicCapitalRatiobeforeLimitedLiability -2.57
9 EconomicCapitalRatio 0.832

Edgar->Model Mapping

Feature Distribution

Change over Time